Clinical Trials
18 trialsNCT06937177 2026-05-11
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy
Endevica Bio
Phase 2 Recruiting
NCT00488072 2026-01-26
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT06518837 2026-01-21
FITWISE
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT04844970 2025-11-17
Anamorelin Study for Advanced Pancreatic Cancer
Lahey Clinic
Phase 2 Terminated
NCT03035409 2025-11-10
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT04871204 2024-10-31
OTIS
Karolinska University Hospital
Phase 2 Completed
NCT03679260 2023-03-30
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance
Cedars-Sinai Medical Center
Phase 2 Completed
NCT02530515 2019-10-29
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00094562 2019-01-18
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00832520 2018-04-10
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT00558558 2016-05-13
Haelan and Nutrition in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02067481 2014-02-20
PREDICOP-F
Institut Català d'Oncologia
Phase 2 Completed
NCT00811824 2013-02-22
Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors
Columbia University
Phase 2 Completed
NCT01206335 2012-11-27
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
Ohr Pharmaceutical Inc.
Phase 2 Unknown
NCT00535015 2008-07-22
Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
Anaborex
Phase 2 Terminated
NCT00196885 2008-06-20
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training
German Cancer Research Center
Phase 2 Completed